First-In-Human, Phase 1, Randomized, Dose-Escalation Trial with Recombinant Anti–IL-20 Monoclonal Antibody in Patients with Psoriasis

por Gottlieb, Alice B., Krueger, James G., Sandberg Lundblad, Mia, Göthberg, Marie, Skolnick, Brett E.
Publicado 2015